Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Cell Rep ; 30(3): 642-657.e6, 2020 01 21.
Artigo em Inglês | MEDLINE | ID: mdl-31968243

RESUMO

Huntington's disease (HD) is caused by an autosomal dominant polyglutamine expansion mutation of Huntingtin (HTT). HD patients suffer from progressive motor, cognitive, and psychiatric impairments, along with significant degeneration of the striatal projection neurons (SPNs) of the striatum. HD is widely accepted to be caused by a toxic gain-of-function of mutant HTT. However, whether loss of HTT function, because of dominant-negative effects of the mutant protein, plays a role in HD and whether HTT is required for SPN health and function are not known. Here, we delete Htt from specific subpopulations of SPNs using the Cre-Lox system and find that SPNs require HTT for motor regulation, synaptic development, cell health, and survival during aging. Our results suggest that loss of HTT function in SPNs could play a critical role in HD pathogenesis.


Assuntos
Corpo Estriado/fisiologia , Proteína Huntingtina/metabolismo , Rede Nervosa/fisiologia , Neurônios/citologia , Neurônios/fisiologia , Sinapses/fisiologia , Envelhecimento/fisiologia , Animais , Comportamento Animal/fisiologia , Sobrevivência Celular , Deleção de Genes , Globo Pálido/fisiologia , Camundongos Knockout , Atividade Motora/fisiologia , Razão Sinal-Ruído
2.
J Neurosci ; 34(28): 9455-72, 2014 Jul 09.
Artigo em Inglês | MEDLINE | ID: mdl-25009276

RESUMO

Huntington's disease (HD) is a neurodegenerative disease caused by the expansion of a poly-glutamine (poly-Q) stretch in the huntingtin (Htt) protein. Gain-of-function effects of mutant Htt have been extensively investigated as the major driver of neurodegeneration in HD. However, loss-of-function effects of poly-Q mutations recently emerged as potential drivers of disease pathophysiology. Early synaptic problems in the excitatory cortical and striatal connections have been reported in HD, but the role of Htt protein in synaptic connectivity was unknown. Therefore, we investigated the role of Htt in synaptic connectivity in vivo by conditionally silencing Htt in the developing mouse cortex. When cortical Htt function was silenced, cortical and striatal excitatory synapses formed and matured at an accelerated pace through postnatal day 21 (P21). This exuberant synaptic connectivity was lost over time in the cortex, resulting in the deterioration of synapses by 5 weeks. Synaptic decline in the cortex was accompanied with layer- and region-specific reactive gliosis without cell loss. To determine whether the disease-causing poly-Q mutation in Htt affects synapse development, we next investigated the synaptic connectivity in a full-length knock-in mouse model of HD, the zQ175 mouse. Similar to the cortical conditional knock-outs, we found excessive excitatory synapse formation and maturation in the cortices of P21 zQ175, which was lost by 5 weeks. Together, our findings reveal that cortical Htt is required for the correct establishment of cortical and striatal excitatory circuits, and this function of Htt is lost when the mutant Htt is present.


Assuntos
Córtex Cerebral/fisiologia , Corpo Estriado/fisiologia , Potenciais Pós-Sinápticos Excitadores/fisiologia , Proteínas do Tecido Nervoso/metabolismo , Proteínas Nucleares/metabolismo , Sinapses/fisiologia , Sinapses/ultraestrutura , Animais , Células Cultivadas , Córtex Cerebral/citologia , Corpo Estriado/citologia , Proteína Huntingtina , Camundongos , Camundongos Transgênicos
3.
Proc Natl Acad Sci U S A ; 108(32): E440-9, 2011 Aug 09.
Artigo em Inglês | MEDLINE | ID: mdl-21788491

RESUMO

Astrocytes regulate synaptic connectivity in the CNS through secreted signals. Here we identified two astrocyte-secreted proteins, hevin and SPARC, as regulators of excitatory synaptogenesis in vitro and in vivo. Hevin induces the formation of synapses between cultured rat retinal ganglion cells. SPARC is not synaptogenic, but specifically antagonizes synaptogenic function of hevin. Hevin and SPARC are expressed by astrocytes in the superior colliculus, the synaptic target of retinal ganglion cells, concurrent with the excitatory synaptogenesis. Hevin-null mice had fewer excitatory synapses; conversely, SPARC-null mice had increased synaptic connections in the superior colliculus. Furthermore, we found that hevin is required for the structural maturation of the retinocollicular synapses. These results identify hevin as a positive and SPARC as a negative regulator of synapse formation and signify that, through regulation of relative levels of hevin and SPARC, astrocytes might control the formation, maturation, and plasticity of synapses in vivo.


Assuntos
Astrócitos/metabolismo , Proteínas de Ligação ao Cálcio/metabolismo , Sistema Nervoso Central/metabolismo , Proteínas da Matriz Extracelular/metabolismo , Neurogênese , Osteonectina/metabolismo , Sinapses/metabolismo , Animais , Astrócitos/citologia , Astrócitos/efeitos dos fármacos , Astrócitos/ultraestrutura , Proteínas de Ligação ao Cálcio/antagonistas & inibidores , Proteínas de Ligação ao Cálcio/química , Proteínas de Ligação ao Cálcio/deficiência , Sistema Nervoso Central/citologia , Sistema Nervoso Central/ultraestrutura , Meios de Cultivo Condicionados/farmacologia , Proteínas da Matriz Extracelular/antagonistas & inibidores , Proteínas da Matriz Extracelular/química , Proteínas da Matriz Extracelular/deficiência , Células HEK293 , Humanos , Camundongos , Neurogênese/efeitos dos fármacos , Osteonectina/química , Osteonectina/deficiência , Estrutura Terciária de Proteína , Ratos , Ratos Sprague-Dawley , Células Ganglionares da Retina/citologia , Células Ganglionares da Retina/efeitos dos fármacos , Células Ganglionares da Retina/metabolismo , Células Ganglionares da Retina/ultraestrutura , Colículos Superiores/citologia , Colículos Superiores/efeitos dos fármacos , Colículos Superiores/metabolismo , Colículos Superiores/ultraestrutura , Sinapses/efeitos dos fármacos , Sinapses/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA